PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Germany.\', \'The First Department of Medicine, Klinikum Ibbenbüren, 49477 Ibbenbüren, Germany.\', \'Department of Cardiology I-Coronary and Peripheral Vascular Disease, Heart Failure Medicine, University Hospital Muenster, 48149 Muenster, Germany.\', \'Department of Medicine D, Division of General Internal and Emergency Medicine, Nephrology, and Rheumatology, University Hospital Muenster, 48149 Muenster, Germany.\', \'Department of Medicine, Gastroenterology, Marienhospital Steinfurt, 48565 Steinfurt, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 232410.3390/v13112324
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 34835130
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all